James Young Simpson discovered the anaesthetic properties of chloroform in 1847 1 and introduced it into clinical practice in Edinburgh. He enthusiastically proclaimed it to be a superior drug to ether. Chloroform proved to be a potent anaesthetic agent and over the next 50 yr its use became widespread throughout the world. However, in 1912 the Committee on Anaesthesia of the American Medical Association pronounced that "The use of chloroform as the anaesthetic for major surgery is no longer justifiable". 2 They were concerned that "delayed chloroform poisoning occurred in a by no means inconsiderable number of cases". At this time, there were no accurate records of the incidence of delayed chloroform poisoning (DCP) and their conclusion was based on case reports backed by experimental animal data. However, subsequent studies and reported series of chloroform anaesthesia in humans have suggested a lower incidence of clinically significant liver injury. We were interested to explore this discrepancy by analysing the published clinical data relating chloroform anaesthesia to liver damage. Information may be divided into three groups: case reports of DCP, large series of chloroform administration and comparative studies.
Case reports
Sheehan published his experience of anaesthesia with chloroform in labouring women. 3 He noted that DCP occurred in patients with severe metabolic derangement after labours of 2-4 days or even longer, and he described the clinical course of illness: day 1: the patient is relatively well; day 2: vomiting occurs, with slight jaundice; day 3: the patient becomes seriously ill with restlessness, delirium, vomiting, upper abdominal pain, increasing jaundice and a low pyrexia; day 4: comatose with "characteristic groaning"; and day 5: deepening coma, increase in temperature and death.
Post-mortem histology showed mid-zonal or centrilobular necrosis of the liver. However, not all patients would develop the full syndrome and die. Davison's description of the clinical illness 4 concurred with Sheehan's account.
In many of the case reports before 1912 it can be seen that the course of illness did not fit that of hepatic damage (table 1) . Therein lies one of the major problems of that time: DCP did not have a defined aetiology and clinical pattern. Because of this, a wide variety of causes of death after anaesthesia were attributed to a late poisonous effect of chloroform. Reading the case reports in table 1 it can be seen, for example, that Heyfelders' two cases 5 are convincing histories of liver failure, whereas others such as Guthrie's publications 9 11 indicate other diagnoses.
Bevan and Favill restricted the array of postoperative deaths attributed to chloroform by defining the underlying role of the liver in 1905. 15 They described late chloroform poisoning as a "hepatic toxaemia" causing vomiting, restlessness, fright, mild delirium, convulsions, coma, Cheyne-Stokes breathing, cyanosis and icterus in varying degree. They wrote that death usually ensued, and that fatty degeneration of the liver was seen post mortem. After their review, the term "delayed chloroform poisoning" (DCP) started to appear widely in the literature and the 1912 committee on anaesthesia equated DCP with necrosis of the liver.
We found 74 cases in the literature dating from before 1912. The evidence for death secondary to liver failure was very variable in these reports, with jaundice documented in only 20 cases. Frequently the finding of a fatty liver at post mortem was thought to be a sign of death secondary to DCP. In all, only 18 cases stand up to scrutiny as being potential instances of death secondary to liver failure, whereas 35 cases have clinical histories which suggest other causes of death. Twenty-one reports do not have enough information to determine if chloroform could have had an influence on the clinical course.
The case reports published after 1912 (table 2 ) have a higher proportion of patients with a clinical history compatible with liver failure. We found 49 case reports of patients with DCP in the literature, and 30 of these had documented jaundice. Eighteen patients had a history compatible with liver failure after chloroform anaesthesia, and only four patients had a history which suggested other pathology. In 27 of the 49 reports there was insufficient evidence to form a conclusion.
Large series (table 3)
The three large series published before 1912 had no documented reports of DCP. Snow, 42 Lawrie 45 and Neve 44 had records of 115 550 chloroform anaesthetics in total. Lawrie and Neve practised anaesthesia in India at the turn of the century. They stand out as having safe records of chloroform anaesthesia; however the nature of postoperative care at this time implied that follow-up of their patients was limited.
Between 1948 and 1970 several articles documented the incidence of hepatic damage after chloroform. Eleven authors documented a total of 310 274 chloroform anaesthetics. There were three deaths from liver failure and another six deaths in which it is unclear if the liver was involved. This gives an incidence of fatalities from liver failure of between 1 in 34 474 and 1 in 103 424. Three more patients with severe hepatic damage recovered. The incidence of documented jaundice was 1 in 10 342.
Comparative studies (table 4)
Nine studies comparing chloroform anaesthesia with control (usually halothane) did not show a clinically significant difference in liver damage. Orth 57 found detectable jaundice in six patients compared with three in the control group. However, numbers in these studies were small.
Discussion
Clearly the problem of liver damage after chloroform anaesthesia is not as great as was feared in 1912. A large number of case reports of DCP do not stand up to scrutiny. In many of these, the description is not that of hepatic failure and in those patients who have a reasonable history of liver damage it is difficult to implicate chloroform as the certain cause. However, it does seem reasonable to assume that there is at least some degree of hepatotoxicity in humans. The mechanism by which this may occur has not been elucidated fully, but it is thought to occur via active metabolites after hepatic metabolism of chloroform. 65 Hepatic chloroform degeneration proceeds by cytochrome p450-dependent oxidative pathways, producing reactive metabolites. These are prevented from covalently binding to microsomal proteins by hepatic glutathione (GSH). Phosgene, a reactive metabolite of chloroform, depletes hepatocellular glutathione. 61 The hepatotoxicity of chloroform may therefore be related to two factors: the rate of biotransformation of chloroform into its active metabolites and the availability of GSH to mop up these metabolites. Enzyme induction increasing the rate of metabolism may occur in association with barbiturates, alcohol and severe starvation, and this may explain the possible increase in hepatic damage with chloroform in patients with these conditions. A direct effect of chloroform on the hepatic microsomal calcium pump has also been suggested. 66 Other causes of liver damage were prominent in the days of chloroform anaesthesia. Hypoxia and hypercapnia cause liver damage, irrespective of the anaesthetic agent used 58 and many anaesthetics were given in which the patient had a poor airway. The lack of supplementary oxygen compounded the problem and it is reasonable to assume that there were many hypoxic patients undergoing the knife. It is worth noting that the excellent safety records of Neve 44 and Lawrie 45 were achieved by anaesthetists who placed great importance on maintaining a clear airway.
In addition, the hepatic effects of chloroform are thought to occur more frequently in those patients with predisposing factors, such as hypoxia, hypercapnia, dehydration and acidosis, and alcoholism. There is no doubt that in the early years of anaesthesia these events were more likely to occur. The possibility of predisposition to liver damage was explored by Ballin in 1903. 12 He reviewed 10 cases of acute yellow atrophy of the liver, eight of which had been given chloroform. He made the point that in every case an inflammatory condition such as appendicitis was present and six of the cases were laparotomies. He thought that this predisposed the liver to the effects of chloroform, and also strongly inferred alcohol as a causative factor.
More recently, others have formed the conclusion that chloroform has had a rough deal. Davison, Wynn and Dykes 55 stated that chloroform was unlikely to produce damage to the liver when used in clinical doses for light anaesthesia. Dykes 67 pointed out that early workers were not successful in proving the existence or determining the incidence of DCP in humans. Davison 4 wrote that chloroform, administered by modern techniques, is no more dangerous than halothane. Strunin 43 analysed the evidence and concluded that chloroform did not entirely fit the criteria required for a drug to be classified as a hepatotoxin. Modern criteria for diagnosing drug-induced hepatotoxicity require stringent investigation. Factors that need to be taken into consideration are the temporal relationship of the disease to starting British Journal of Anaesthesia 1997; 79: Modern anaesthesia provides accurate delivery of anaesthetic agents, and diligently monitors the airway and cardiovascular status. Given these accepted prerequisites for safe anaesthesia, chloroform does not have a high incidence of clinically significant hepatic damage. The incidence of hepatic failure after chloroform is between 1 in 25 800 and 1 in 51 700 and compares favourably with halothane, which is quoted as 1 in 35 000. Chloroform (58) vs halothane (42) vs regional anaesthesia (12) No significant difference in liver function tests except BSP retention higher with chloroform
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